Velocity’s research site in Slidell was founded in 2019 as part of MedPharmics, and acquired by Velocity in 2022. Since its inception, the site has built a reputation of success conducting trials in Infectious Diseases and Women’s Health. Additionally, our Slidell site conducts pediatric trials and is actively expanding to new therapeutic areas.
Located near I-12 on Brownswitch Road, the site is easily accessible. The stand-alone building is fully equipped to accommodate various types of clinical trials. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Slidell team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.